Found: 21
Select item for more details and to access through your institution.
Circulating microRNAs Signature for Predicting Response to GLP1-RA Therapy in Type 2 Diabetic Patients: A Pilot Study.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 17, p. 9454, doi. 10.3390/ijms22179454
- By:
- Publication type:
- Article
Non-Coding RNAs: Novel Players in Insulin Resistance and Related Diseases.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 14, p. 7716, doi. 10.3390/ijms22147716
- By:
- Publication type:
- Article
The Landscape of microRNAs in βCell: Between Phenotype Maintenance and Protection.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 2, p. 803, doi. 10.3390/ijms22020803
- By:
- Publication type:
- Article
Targeting microRNAs as a Therapeutic Strategy to Reduce Oxidative Stress in Diabetes.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 24, p. 6358, doi. 10.3390/ijms20246358
- By:
- Publication type:
- Article
Reduced miR-184-3p expression protects pancreatic β-cells from lipotoxic and proinflammatory apoptosis in type 2 diabetes via CRTC1 upregulation.
- Published in:
- Cell Death Discovery, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41420-022-01142-x
- By:
- Publication type:
- Article
Increased Expression of Viral Sensor MDA5 in Pancreatic Islets and in Hormone-Negative Endocrine Cells in Recent Onset Type 1 Diabetic Donors.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.833141
- By:
- Publication type:
- Article
Intra-islet insulin synthesis defects are associated with endoplasmic reticulum stress and loss of beta cell identity in human diabetes.
- Published in:
- Diabetologia, 2023, v. 66, n. 2, p. 354, doi. 10.1007/s00125-022-05814-2
- By:
- Publication type:
- Article
SARS-CoV-2 Receptor Angiotensin I-Converting Enzyme Type 2 (ACE2) Is Expressed in Human Pancreatic β -Cells and in the Human Pancreas Microvasculature.
- Published in:
- Frontiers in Endocrinology, 2020, v. 11, p. N.PAG, doi. 10.3389/fendo.2020.596898
- By:
- Publication type:
- Article
Pancreatic Alpha-Cells Contribute Together With Beta-Cells to CXCL10 Expression in Type 1 Diabetes.
- Published in:
- Frontiers in Endocrinology, 2020, v. 11, p. N.PAG, doi. 10.3389/fendo.2020.00630
- By:
- Publication type:
- Article
Sexual Function and Endocrine Profile in Fertile Women With Type 1 Diabetes.
- Published in:
- Diabetes Care, 2006, v. 29, n. 2, p. 312, doi. 10.2337/diacare.29.02.06.dc05-1067
- By:
- Publication type:
- Article
Extracellular Vesicles in Immune System Regulation and Type 1 Diabetes: Cell-to-Cell Communication Mediators, Disease Biomarkers, and Promising Therapeutic Tools.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.682948
- By:
- Publication type:
- Article
NF-κB-inducing kinase (NIK) is activated in pancreatic β-cells but does not contribute to the development of diabetes.
- Published in:
- Cell Death & Disease, 2022, v. 13, n. 5, p. 1, doi. 10.1038/s41419-022-04931-5
- By:
- Publication type:
- Article
Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy.
- Published in:
- Hematological Oncology, 2013, v. 31, n. 3, p. 143, doi. 10.1002/hon.2037
- By:
- Publication type:
- Article
Angiotensin I‐converting enzyme type 2 expression is increased in pancreatic islets of type 2 diabetic donors.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2023, v. 39, n. 8, p. 1, doi. 10.1002/dmrr.3696
- By:
- Publication type:
- Article
Six-month oral clarithromycin regimen is safe and active in extranodal marginal zone B-cell lymphomas: final results of a single-centre phase II trial.
- Published in:
- 2010
- By:
- Publication type:
- Letter
A Reappraisal of the Diagnostic and Therapeutic Management of Uncommon Histologies of Primary Ocular Adnexal Lymphoma.
- Published in:
- Oncologist, 2013, v. 18, n. 7, p. 876, doi. 10.1634/theoncologist.2012-0425
- By:
- Publication type:
- Article
Clinical Relevance of the Dose of Cytarabine in the Upfront Treatment of Primary CNS Lymphomas with Methotrexate-Cytarabine Combination.
- Published in:
- Oncologist, 2011, v. 16, n. 3, p. 336, doi. 10.1634/theoncologist.2010-0361
- By:
- Publication type:
- Article
Outer Membrane Vesicles From The Gut Microbiome Contribute to Tumor Immunity by Eliciting Cross-Reactive T Cells.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.912639
- By:
- Publication type:
- Article
A Plasma miR-193b-365 Signature Combined With Age and Glycemic Status Predicts Response to Lactococcus lactis–Based Antigen-Specific Immunotherapy in New-Onset Type 1 Diabetes.
- Published in:
- Diabetes, 2023, v. 72, n. 10, p. 1470, doi. 10.2337/db22-0852
- By:
- Publication type:
- Article
290-OR: Altered In-Situ Expression of Proinsulin-Insulin in Pancreatic Islets Reflects Metabolic and Molecular Defects in Type 2 Diabetic and Glucose-Intolerant Living Donors.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-290-OR
- By:
- Publication type:
- Article
1795-P: Proinsulin-Insulin Pancreatic Islets In-situ Expression Mirrors Metabolic Defects Observed in Type 2 Diabetic and Glucose Intolerant Living Donors.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1795-P
- By:
- Publication type:
- Article